← 返回

scRNA-seq 揭示复发 T-ALL 中的免疫微环境和 JUN 介导的 NK 细胞耗竭

英文原题:scRNA-seq reveals an immune microenvironment and JUN-mediated NK cell exhaustion in relapsed T-ALL.

查看英文原题

scRNA-seq reveals an immune microenvironment and JUN-mediated NK cell exhaustion in relapsed T-ALL.

PubMed 2025/04/29(内容时间) Cell Rep Med Q1 · IF 14(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

T细胞急性淋巴细胞白血病(T-ALL)是一种以高复发率为特征的异质性疾病。通过单细胞转录组分析,我们刻画了T-ALL患者骨髓免疫微环境的特征,鉴定出13个主要细胞簇。这些患者表现出异常扩增的造血干细胞(HSCs)和粒-单核祖细胞(GMPs),以及CD4+ T细胞、CD8+ T细胞和自然杀伤(NK)细胞中的免疫抑制特征。对CD4+ T细胞进行细分,揭示了两个在T辅助(Th)1/Th2之间过渡的亚群,即Annexin-A1(ANXA1)- GATA3 - CD4+ T和ANXA1 + GATA3 + CD4+ T。

此外,NK细胞在复发T-ALL患者的肿瘤微环境中表现出耗竭,JUN被鉴定为关键因子。此外,JUN在T-ALL中也高表达,并且对其维持增殖至关重要。JUN抑制剂对白血病细胞表现出成功的致死作用,并改善了复发T-ALL细胞系中的NK细胞耗竭,以及在细胞源性肿瘤异种移植(CDX)、患者源性肿瘤异种移植(PDX)和NOTCH1突变小鼠模型中也是如此。

总之,我们的发现增进了对T-ALL复发机制的理解,并支持为复发T-ALL患者开发创新的免疫疗法。

展开英文摘要原文

T cell acute lymphoblastic leukemia (T-ALL) is a heterogeneous disease characterized by a high relapse rate. By single-cell transcriptome analysis, we characterize the bone marrow immune microenvironment in patients with T-ALL, identifying 13 major cell clusters.

These patients exhibited abnormally expanded hematopoietic stem cells (HSCs) and granulocyte-monocyte progenitors (GMPs), immunosuppressive traits in CD4 + T, CD8 + T, and natural killer (NK) cells. Subdividing CD4 + T cells reveal two subsets transitioning between T helper (Th)1/Th2, Annexin-A1 (ANXA1) - GATA3 - CD4 + T, and ANXA1 + GATA3 + CD4 + T.

Additionally, NK cells demonstrate exhaustion in the tumor microenvironment of patients with relapsed T-ALL, with JUN identified as a critical factor.

Additionally, JUN is also highly expressed in T-ALL and is crucial for maintaining its proliferation. The JUN inhibitor exhibited successful lethality toward leukemia cells and ameliorated NK cell exhaustion in relapsed T-ALL cell line, as well as in cell-derived tumor xenograft (CDX), patient-derived tumor xenograft (PDX), and NOTCH1-mutant mouse models. In summary, our findings enhance the understanding of T-ALL relapse mechanisms and support the development of innovative immunotherapies for patients with relapsed T-ALL.

论文信息

作者
Liu Y、Du Z、Li L、Huang J、Liu S、Lu B、Duan Y、Cheng Y
第一作者单位
Pediatric Hematology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518107, Guangdong, China; Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518107, Guangdong, China.China
通讯作者单位
Pediatric Hematology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518107, Guangdong, China. Electronic address: chenchun@mail.sysu.edu.cn.China
期刊
Cell reports. Medicine2025 May 20
原文标识
PubMed 40306275 · DOI 10.1016/j.xcrm.2025.102098